Connor, Clark & Lunn Investment Management (CC&L)’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.06M | Sell |
|
|||||
|
2025
Q1 | $3.91M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $200K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $3.2M | Buy |
|
|||||
|
2022
Q4 | $556K | Sell |
|
|||||
|
2022
Q3 | $1.32M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $203K | Sell |
|
|||||
|
2021
Q4 | $246K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $189K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $55K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $70K | Buy |
|
|||||
|
2018
Q3 | $117K | Buy |
|
|||||
|
2018
Q2 | $78K | Buy |
|